Skip to main content

EPA acts twice on PFAS

21st April 2024

Submitted by:

Andrew Warmington

The US Environmental Protection Agency (EPA) has taken two separate actions on per- and polyfluorinated substances (PFAS), both being part of its PFAS strategic roadmap, which aims to implement legislation by Q4 to reduce and destroy PFAS contamination in water, air and soil.

Under the National Primary Drinking Water Regulation, the agency has laid down new standards with legally enforceable maximum contaminant levels (MCLs) on five individual PFAS. These are more stringent than previously mooted limits:

* 4 parts per trillion (ppt) for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS); and

* 10 ppt for perfluorononanoic acid (PFNA), perfluorohexane sulfonate (PFHxS) and hexafluoropropylene oxide-dimer acid, or GenX

Combinations of two or more of PFNA, PFHxS, GenX and perfluorobutane sulfonate (PFBS) also face limits. However, the short-chain species of PFAS, perfluorobutanoic acid (PFBA), is not included. Some critics noted that, although it is less toxic that C8 compounds, PFBA is harder to remove from water because it does not readily adsorb to surfaces.

Public water systems have three years to begin monitoring and two more to implement compliance systems. An estimated 6-10% of the public drinking water systems subject to the rule will have to act to meet these new standards. Chemical manufacturers are not directly impacted but the EPA believes that they will be under pressure from water companies to release fewer PFAS.

The agency is offering nearly $1 billion to help states implement testing and treatment and to assist owners of private wells. However, the American Water Works Association said that compliance will cost around $1.5 billion/year and will not bring significant health benefits.

The American Chemistry Council (ACC) argued that peer-reviewed research questions “the basis for EPA’s overly conservative approach to assessing one of the health endpoints. Even EPA’s own Science Advisory Board severely criticised much of the underlying science behind the proposed standards.” In addition, the ACC added, “since this proposal was first announced, new real-world data has become available through national monitoring that confirms the rationale for this proposal is based on inaccurate and out-of-date information … We strongly support the establishment of a science-based drinking water standard, but this rushed, unscientific approach is unacceptable.”

A few days later, the EPA announced a final ruling designating PFOA and PFOS as hazardous substances under the Comprehensive Environmental Response, Compensation & Liability Act (CERCLA, or Superfund). The designation requires entities to immediately report releases of over 1 lb (0.4536 kg) within 24 hours to the National Response Centre and state, tribal and local emergency responders.

The agency also set an enforcement discretion policy focused on parties that significantly contributed to the release of PFAS into the environment, including parties that have used them in manufacturing processes, in federal facilities and other industrial parties. A Final Rule will be published in the Federal Register and will take effect 60 days later.

The ACC, noting that PFPA and PFOS have not been produced in the US for over ten years, again questioned the scientific basis for the ruling. “Furthermore, CERCLA is an expensive, ineffective and unworkable means to achieve remediation for these chemicals. CERCLA is fraught with unintended consequences and will likely result in extensive, unnecessary delays for clean-ups,” it said.

While some environmental groups welcomed the move, Public Employees for Environmental Responsibility (PEER) said that the approach failed to address the many PFAS with terminal end products that end up as PFOS and PFOA. “These regulations allow industry to substitute new PFAS variations faster than the EPA can regulate them,” PEER said. Only a total ban would eradicate contamination.

Separately, a US district court has approved a settlement of hundreds of lawsuits by water suppliers against 3M. The company will pay them at least $10.3 billion over the next 13 years to spend on PFAS testing and remediation, plus up to $2.2 billion more if further contamination is found. This follows similar settlements by DuPont, Chemours and Corteva.

This may not be the end of the matter, however. In July 2023, after the agreement was first announced, over 20 attorney generals filed a motion in opposition, arguing that the total fell short of what was really needed and would shift the burden onto local water suppliers and taxpayers.

3M was the first producer of PFAS chemicals in 1956 and the largest overall. It phased out PFOA and PFOS from 2000 once their toxicity and persistence in humans, animals and the environment became clear, but continued to make other PFAS compounds with different properties until 2022.

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after a week after the latter declined to engage with it.

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington